Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effects of Paroxetine on Cardiovascular Function in Septic Patients
Sponsor: Universidade do Extremo Sul Catarinense - Unidade Academica de Ciecias da Saude
Summary
It is known that septic shock is characterized by arterial hypotension, decreased peripheral vascular resistance and hyporeactivity to vasoconstrictor agents, with NO being an important mediator of this organ dysfunction. Data in the literature have shown that hyporeactivity to catecholamines is associated with a decrease in the density of α and ß receptors in the aorta and heart, respectively, as well as an increase in GRK2 levels and that NO contributes to the increase of this kinase in sepsis . Based on this, it is hypothesized that cardiac dysfunction and decreased peripheral vascular resistance observed in sepsis may result from an increase in GRK2 activity and/or expression and its inhibition may be a relevant therapeutic target in septic shock patients. Based on this line, a measurable clinical benefit of paroxetine through the regulation of GRK2 expression in patients with septic shock is postulated.
Official title: Effects of Paroxetine on Cardiovascular Function in Septic Patients: a Randomized Placebo Controlled Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
92
Start Date
2023-06-10
Completion Date
2025-04-15
Last Updated
2025-01-06
Healthy Volunteers
No
Conditions
Interventions
Paroxetine
Paroxetine, 40mg/day, once a day, for 05 consecutive days or 24 hours after shock resolution
Locations (2)
Hospital Maternidade São José de Colatina
Colatina, Espírito Santo, Brazil
Hospital São José
Criciúma, Santa Catarina, Brazil